Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY

LIPPINCOTT WILLIAMS & WILKINS

1. NIH [UM1-HL120877, F32-HL134244, L30-GM120751]
2. DoD Peer Reviewed Medical Research Program [W81XWH-16-1-0464]